Arrowhead Pharmaceuticals grants up to 196,885 restricted stock units to 203 new employees
ARWR•Arrowhead Pharmaceuticals granted 203 new employees up to 196,885 restricted stock units, approved on October 22, 2026, that vest annually over four years outside stockholder-approved equity incentive plans.
1. Employee stock grants
Arrowhead Pharmaceuticals awarded 203 new employees grants totaling up to 196,885 restricted stock units. Approved on October 22, 2026, the units vest annually over four years outside stockholder-approved equity incentive plans.




